Meyer JS, Welch KM, Deshmukh VD, et al. Neurotransmitter precursor amino acids in the treatment of multi-infarct dementia and Alzheimer's disease. J Amer Geriat Soc 1977;25:289-98.
Lieberman HR, Corkin S, Spring BJ. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 1985;42:366-70.
DiPiro JT, Talbert RL, Yee GC, et al; eds. Pharmacotherapy: A pathophysiologic approach. 4th ed. Stamford, CT: Appleton & Lange, 1999.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg 1999;125:1091-8.
Gelenberg AJ, Wojcik JD, Falk WE, et al. Tyrosine for depression: a double-blind trial. J Affect Disord 1990;19:125-32.
Eisenberg J, Asnis GM, van Praag HM, Vela RM. Effect of tyrosine on attention deficit disorder with hyperactivity. J Clin Psychiatr 1988;49:193-5.
Reimherr FW, Wender PH, Wood DR, Ward M. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. Am J Psychiatr 1987;144:1071-3.
Wood DR, Reimherr FW, Wender PH. Amino acid precursors for the treatment of attention deficit disorder, residual type. Psychopharmacol Bull 1985;21:146-9.
van Spronsen FJ, van Rijn M, Bekhof J. Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets. Am J Clin Nutr 2001;73:153-7.
Poustie VJ, Rutherford P. Tyrosine supplementation for phenylketonuria. Cochrane Database Syst Rev 2000;2:CD001507.
Roberts SA, Thorpe JM, Ball RO, Pencharz PB. Tyrosine requirement of healthy men receiving a fixed phenylalanine intake determined by using indicator amino acid oxidation. Am J Clin Nutr 2001 Feb;73:276-82.
Neri DF, Wiegmann D, Stanny RR, et al. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med 1995;66:313-9.
Food and Nutrition Board, Institute of Medicine. The Role of Protein and Amino Acids in Sustaining and Enhancing Performance. Washington, DC: National Academy Press, 1999. Available at: https://www.nap.edu/books/0309063469/html/.
NIH Consensus Statement. Phenylketonuria: Screening and Management. October 16-18, 2000. Pediatrics 2001;108:972-82.
Deijen, J. B., Wientjes, C. J., Vullinghs, H. F., Cloin, P. A., and Langefeld, J. J. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull 1-15-1999;48(2):203-209.
Thomas, J. R., Lockwood, P. A., Singh, A., and Deuster, P. A. Tyrosine improves working memory in a multitasking environment. Pharmacol Biochem Behav 1999;64(3):495-500.
Meyers, S. Use of neurotransmitter precursors for treatment of depression. Altern Med Rev 2000;5(1):64-71.
Chinevere, T. D., Sawyer, R. D., Creer, A. R., Conlee, R. K., and Parcell, A. C. Effects of L-tyrosine and carbohydrate ingestion on endurance exercise performance. J Appl.Physiol 2002;93(5):1590-1597.
Magill, R. A., Waters, W. F., Bray, G. A., Volaufova, J., Smith, S. R., Lieberman, H. R., McNevin, N., and Ryan, D. H. Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr.Neurosci. 2003;6(4):237-246.
Sutton, E. E., Coill, M. R., and Deuster, P. A. Ingestion of tyrosine: effects on endurance, muscle strength, and anaerobic performance. Int.J.Sport Nutr.Exerc.Metab 2005;15(2):173-185.
Belza, A., Frandsen, E., and Kondrup, J. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Int.J.Obes.(Lond) 2007;31(1):121-130.
O'Brien, C., Mahoney, C., Tharion, W. J., Sils, I. V., and Castellani, J. W. Dietary tyrosine benefits cognitive and psychomotor performance during body cooling. Physiol Behav. 2-28-2007;90(2-3):301-307.
Mahoney, C. R., Castellani, J., Kramer, F. M., Young, A., and Lieberman, H. R. Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiol Behav. 11-23-2007;92(4):575-582.
Ryan, M. M., Sy, C., Rudge, S., Ellaway, C., Ketteridge, D., Roddick, L. G., Iannaccone, S. T., Kornberg, A. J., and North, K. N. Dietary L-tyrosine supplementation in nemaline myopathy. J.Child Neurol. 2008;23(6):609-613.
Palinkas, L. A., Reedy, K. R., Smith, M., Anghel, M., Steel, G. D., Reeves, D., Shurtleff, D., Case, H. S., Van, Do N., and Reed, H. L. Psychoneuroendocrine effects of combined thyroxine and triiodothyronine versus tyrosine during prolonged Antarctic residence. Int.J.Circumpolar.Health 2007;66(5):401-417.
Chadwick, M. J., Gregory, D. L., and Wendling, G. A double-blind amino acids, L-tryptophan and L-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center. Am J Drug Alcohol Abuse 1990;16(3-4):275-286.
Lemoine, P., Robelin, N., Sebert, P., and Mouret, J. [L-tyrosine: a long term treatment of Parkinson's disease]. C.R.Acad Sci III 1989;309(2):43-47.
Elwes, R. D., Crewes, H., Chesterman, L. P., Summers, B., Jenner, P., Binnie, C. D., and Parkes, J. D. Treatment of narcolepsy with L-tyrosine: double-blind placebo- controlled trial. Lancet 11-4-1989;2(8671):1067-1069.
Furst, P. Amino acid metabolism in uremia. J.Am.Coll.Nutr. 1989;8(4):310-323.
Banderet, L. E. and Lieberman, H. R. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res Bull 1989;22(4):759-762.
Lou, H. Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria. Lancet 7-20-1985;2(8447):150-151.
Mouret, J., Lemoine, P., Sanchez, P., Robelin, N., Taillard, J., and Canini, F. Treatment of narcolepsy with L-tyrosine. Lancet 12-24-1988;2(8626-8627):1458-1459.
Sole, M. J., Benedict, C. R., Myers, M. G., Leenen, F. H., and Anderson, G. H. Chronic dietary tyrosine supplements do not affect mild essential hypertension. Hypertension 1985;7(4):593-596.
Reinstein, D. K., Lehnert, H., and Wurtman, R. J. Dietary tyrosine suppresses the rise in plasma corticosterone following acute stress in rats. Life Sci. 12-9-1985;37(23):2157-2163.
Goldberg, I. K. L-tyrosine in depression. Lancet 8-16-1980;2(8190):364.
Growdon, J. H., Melamed, E., Logue, M., Hefti, F., and Wurtman, R. J. Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sci. 3-8-1982;30(10):827-832.
Alvestrand, A., Furst, P., and Bergstrom, J. Intracellular amino acids in uremia. Kidney Int.Suppl 1983;16:S9-16.
Alvestrand, A., Ahlberg, M., Furst, P., and Bergstrom, J. Clinical results of long-term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia. Clin.Nephrol. 1983;19(2):67-73.
Rasmussen, D. D., Ishizuka, B., Quigley, M. E., and Yen, S. S. Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations. J.Clin.Endocrinol.Metab 1983;57(4):760-763.
Batshaw, M. L., Valle, D., and Bessman, S. P. Unsuccessful treatment of phenylketonuria with tyrosine. J.Pediatr. 1981;99(1):159-160.
Gelenberg, A. J., Wojcik, J. D., Growdon, J. H., Sved, A. F., and Wurtman, R. J. Tyrosine for the treatment of depression. Am J Psychiatry 1980;137(5):622-623.
Dollins, A. B., Krock, L. P., Storm, W. F., Wurtman, R. J., and Lieberman, H. R. L-tyrosine ameliorates some effects of lower body negative pressure stress. Physiol Behav. 1995;57(2):223-230.
Shurtleff, D., Thomas, J. R., Schrot, J., Kowalski, K., and Harford, R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol Biochem Behav 1994;47(4):935-941.
Deijen, J. B. and Orlebeke, J. F. Effect of tyrosine on cognitive function and blood pressure under stress. Brain Res Bull 1994;33(3):319-323.
van Spronsen, F. J., van Dijk, T., Smit, G. P., van Rijn, M., Reijngoud, D. J., Berger, R., and Heymans, H. S. Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am J Clin Nutr 1996;64(6):916-921.
Smith, M. L., Hanley, W. B., Clarke, J. T., Klim, P., Schoonheyt, W., Austin, V., and Lehotay, D. C. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria. Arch Dis Child 1998;78(2):116-121.
Struder, H. K., Hollmann, W., Platen, P., Donike, M., Gotzmann, A., and Weber, K. Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm Metab Res 1998;30(4):188-194.
Mouret, J., Lemoine, P., Sanchez, P., Robelin, N., and Canini, F. \ET/ Treatment of narcolepsy with L-tyrosine. Lancet (England) 1988;2:1458-1459.
Alonso, Raf. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans. Biological Psychiatry 1982;17(7):781-790.
Blum K. A commentary on neurotransmitter restoration as a common mode of treatment for alcohol, cocaine and opiate abuse. Integr Psychiatr 1986;6:199-204.
Ma, Yong, Ha, Zhende, Zhang, Xizhou, Wang, Wei, Cui, Jianhua, Zhang, Fang, and Zhu, Yongan. Effect of tyrosine and acetazolamide on the brain-body functions of healthy young men living in high altitudes. Chinese Mental Health Journal 2002;16(7):465-467.
Deutsch, Stephen I., Rosse, Richard B., Schwartz, Barbara L., and Banay-Schwartz, Miriam. L-tyrosine pharmacotherapy of schizophrenia: Preliminary data. Clinical Neuropharmacology 1994;17(1):53-62.
Tyrrell HA and Maher TJ. Tyrosine: Food supplement or therapeutic agent? Journal of Nutritional Medicine 1998;8(4):349-359.
Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts. J Huazhong Univ Sci Technolog Med Sci 2012;32(3):422-7.
Bjork JM, Grant SJ, Chen G, Hommer DW. Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing. Neuropsychopharmacology. 2014;39(3):595-604.
Colzato LS, Jongkees BJ, Sellaro R, van den Wildenberg WP, Hommel B. Eating to stop: tyrosine supplementation enhances inhibitory control but not response execution. Neuropsychologia. 2014;62:398-402.
Dowlati Y, Ravindran AV, Maheux M, Steiner M, Stewart DE, Meyer JH. No effect of oral tyrosine on total tyrosine levels in breast milk: implications for dietary supplementation in early postpartum. Arch Womens Ment Health. 2014;17(6):541-8.
Steenbergen L, Sellaro R, Hommel B, Colzato LS. Tyrosine promotes cognitive flexibility: evidence from proactive vs. reactive control during task switching performance. Neuropsychologia. 2015;69:50-5.
Tumilty L, Davison G, Beckmann M, Thatcher R. Failure of oral tyrosine supplementation to improve exercise performance in the heat. Med Sci Sports Exerc. 2014;46(7):1417-25.
Webster D, Wildgoose J. Tyrosine supplementation for phenylketonuria. Cochrane Database Syst Rev. 2013 5;(6):CD001507.
Singh RH, Rohr F, Frazier D, et al. Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med. 2014;16(2):121-31.
van de Rest O, Bloemendaal M, de Heus R, Aarts E. Dose-dependent effects of oral tyrosine administration on plasma tyrosine levels and cognition in aging. Nutrients 2017;9(12). pii: E1279.
Stock AK, Colzato L, Beste C. On the effects of tyrosine supplementation on interference control in a randomized, double-blind placebo-control trial. Eur Neuropsychopharmacol. 2018;28(8):933-944.
Soranzo A, Aquili L. Fear expression is suppressed by tyrosine administration. Sci Rep. 2019;9(1):16073.
Tumilty L, Gregory N, Beckmann M, Thatcher R. No influence of low-, medium-, or high-dose tyrosine on exercise in a warm environment. Med Sci Sports Exerc. 2020;52(6):1404-1413.
Mathar D, Erfanian Abdoust M, Marrenbach T, Tuzsus D, Peters J. The catecholamine precursor Tyrosine reduces autonomic arousal and decreases decision thresholds in reinforcement learning and temporal discounting. PLoS Comput Biol 2022;18(12):e1010785.
Umeda K, Shindo D, Somekawa S, et al. Effects of Five Amino Acids (Serine, Alanine, Glutamate, Aspartate, and Tyrosine) on Mental Health in Healthy Office Workers: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial. Nutrients 2022;14(11):2357.
Kruszewski M, Merchelski M, Kruszewski A,Tabecki R, Aksenov MO, and Pagowski L. Effects of Multi-Ingredient Pre-Workout Supplement and Caffeine on Bench Press Performance: A Single-Blind Cross-Over Study. Nutrients 2022;14(9):1750.
You Might Also Like
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.